Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Solventum Community
NYSE:SOLV Community
1
Narratives
written by author
0
Comments
on narratives written by author
30
Fair Values set
on narratives written by author
Create a narrative
Solventum
Popular
Undervalued
Overvalued
Community Investing Ideas
Solventum
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
New VAC Product And AI Will Simplify Procedures
Key Takeaways Streamlining operations and divesting non-core assets are expected to improve margins, reduce leverage, and focus growth efforts on core segments. Innovations in product offerings and AI-driven technology aim to enhance efficiency, drive revenue growth, and boost net margins.
View narrative
US$80.89
FV
15.2% undervalued
intrinsic discount
0.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
Updated
narrative
Your Valuation for
SOLV
SOLV
Solventum
Your Fair Value
US$
Current Price
US$68.58
49.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
8b
2015
2018
2021
2024
2025
2027
2030
Revenue US$8.3b
Earnings US$484.0m
Advanced
Set Fair Value